Adiponectin pathway attenuates malignant mesothelioma cell growth

American Journal of Respiratory Cell and Molecular Biology

Volumn 46, Issue 4, 2012, Pages 515-523

  Niu, Kaijun ^a,b   Asada, Masanori ^b   Okazaki, Tatsuma ^b   Yamanda, Shinsuke ^b   Ebihara, Takae ^b   Guo, Hui ^b   Zhang, Dongying ^b   Nagatomi, Ryoichi ^b   Arai, Hiroyuki ^b   Kohzuki, Masahiro ^a   Ebihara, Satoru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Adiponectin; AMP activated protein kinase; Cyclooxygenase 2; Fish oils; Malignant mesothelioma

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CYCLOOXYGENASE 2; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; PROSTAGLANDIN E2; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; DOWN REGULATION; DOWNSTREAM PROCESSING; ENERGY METABOLISM; GENE SILENCING; GROWTH DISORDER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MALIGNANT MESOTHELIOMA; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADIPONECTIN; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CYCLOOXYGENASE 2; DIET; FISH OILS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MESOTHELIOMA; MICE; MICE, INBRED STRAINS; MICE, SCID; PROTEIN KINASES; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84859413154     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0068OC     Document Type: Article

References (38)

1. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-672. (Pubitemid 29046253)
2. Sterman DH, Kaiser LR, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest 1999;116:504-520. (Pubitemid 29382138)
3. Kim KU, Wilson SM, Abayasiriwardana KS, Collins R, Fjellbirkeland L, Xu Z, Jablons DM, Nishimura SL, Broaddus VC. A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance. Am J Respir Cell Mol Biol 2005;33:541-548. (Pubitemid 41753129)
4. Kamp DW, Weitzman SA. The molecular basis of asbestos induced lung injury. Thorax 1999;54:638-652. (Pubitemid 29296687)
5. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-2644. (Pubitemid 46606305)
6. Granados S, Quiles JL, Gil A, Ramirez-Tortosa MC. Dietary lipids and cancer. Nutr Hosp 2006;21(Suppl 2):42-52, 44-54. Review.
7. Neschen S, Morino K, Rossbacher JC, Pongratz RL, Cline GW, Sono S, Gillum M, Shulman GI. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes 2006;55:924-928. (Pubitemid 44100165)
8. Banga A, Unal R, Tripathi P, Pokrovskaya I, Owens RJ, Kern PA, Ranganathan G. Adiponectin translation is increased by the PPAR-gamma agonists pioglitazone and omega-3 fatty acids. Am J Physiol Endocrinol Metab 2009;296:E480-E489.
9. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96:1723-1732. (Pubitemid 30661055)
10. Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 2004;101:2476-2481. (Pubitemid 38269336)
11. Barb D, Neuwirth A, Mantzoros CS, Balk SP. Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway. Endocr Relat Cancer 2007;14:995-1005. (Pubitemid 351252431)
12. Cong L, Gasser J, Zhao J, Yang B, Li F, Zhao AZ. Human adiponectin inhibits ell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Endocr Relat Cancer 2007;14:713-720. (Pubitemid 350074060)
13. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007;13:332-339. (Pubitemid 46376688)
14. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2006;345:271-279.
15. Hwang JT, Kim YM, Surh YJ, Baik HW, Lee SK, Ha J, Park OJ. Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells. Cancer Res 2006;66:10057-10063. (Pubitemid 44672059)
16. Park IJ, Hwang JT, Kim YM, Ha J, Park OJ. Differential modulation of AMPK signaling pathways by low or high levels of exogenous reactive oxygen species in colon cancer cells. Ann N Y Acad Sci 2006;1091: 102-109. (Pubitemid 47092229)
17. Shin JI, Lee YK, Kim YM, Hwang JT, Park OJ. Possible link between no concentrations and COX-2 expression in systems treated with soyisoflavones. Ann N Y Acad Sci 2007;1095:564-573.
18. Hwang JT, Ha J, Park IJ, Lee SK, Baik HW, Kim YM, Park OJ. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett 2007;247:115-121. (Pubitemid 46001507)
19. Marrogi A, Pass HI, Khan M, Metheny-Barlow LJ, Harris CC, Gerwin BI. Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor. Cancer Res 2000;60: 3696-3700. (Pubitemid 32204553)
20. O'Kane SL, Cawkwell L, Campbell A, Lind MJ. Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma. Eur J Cancer 2005;41:1645-1648. (Pubitemid 40981848)
21. Hwang JT, Ha J, Park OJ. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 2005;332:433-440. (Pubitemid 40731495)
22. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary longchain N-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004;79:935-945. (Pubitemid 41095944)
23. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638. (Pubitemid 36459468)
24. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001;411:390-395. (Pubitemid 32467050)
25. Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007;14:189-206. (Pubitemid 47242622)
26. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005;11:1096-1103. (Pubitemid 41486832)
27. Yokota T, Meka CS, Kouro T, Medina KL, Igarashi H, Takahashi M, Oritani K, Funahashi T, Tomiyama Y, Matsuzawa Y, et al. Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J Immunol 2003;171:5091-5099. (Pubitemid 37432791)
28. Ujiie H, Oritani K, Kato H, Yokota T, Takahashi I, Maeda T, Masaie H, Ichii M, Kamada Y, Tamura S, et al. Identification of amino-terminal region of adiponectin as a physiologically functional domain. J Cell Biochem 2006;98:194-207.
29. Ledoux S, Campos DB, Lopes FL, Dobias-Goff M, Palin MF, Murphy BD. Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 2006;147:5178-5186. (Pubitemid 44790572)
30. Rattan R, Giri S, Singh AK, Singh I. 5-aminoimidazole-4-carboxamide- 1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J Biol Chem 2005;280: 39582-39593. (Pubitemid 41713917)
31. Luo XH, Guo LJ, Yuan LQ, Xie H, Zhou HD, Wu XP, Liao EY. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005;309: 99-109. (Pubitemid 41191227)
32. Dagon Y, Avraham Y, Berry EM. AMPK activation regulates apoptosis, adipogenesis, and lipolysis by EIF2alpha in adipocytes. Biochem Biophys Res Commun 2006;340:43-47. (Pubitemid 41827645)
33. Hardie DG. The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci 2004;117:5479-5487. (Pubitemid 40012195)
34. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762-769. (Pubitemid 36735700)
35. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006;64:355-365.
36. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799-1804. (Pubitemid 37430249)
37. Hamdy O. Lifestyle modification and endothelial function in obese subjects. Expert Rev Cardiovasc Ther 2005;3:231-241. (Pubitemid 40424942)
38. Muscat JE, Huncharek M. Dietary intake and the risk of malignant mesothelioma. Br J Cancer 1996;73:1122-1125. (Pubitemid 26131235)